Advertisement

AAO 2020 – Wet AMD

AAO 2020: HBM9036 Nasal Spray for Dry Eye Disease

HBM9036 ophthalmic solution 0.25%,  also known as tanfanercept, a novel TNF-α inhibitor, is safe and effective for improving certain symptoms of dry eye disease, according to results of a phase 2 randomized, a double-blind...

Assessing a Novel Contrast Sensitivity Function Test in AMD

Contrast sensitivity is a key metric of visual function that strongly correlates with visual impairment and daily functional vision. Patients with age-related macular degeneration (AMD) often complain of visual dysfunction in...

AAO 2020: HBM9036 Nasal Spray for Dry Eye Disease

HBM9036 ophthalmic solution 0.25%,  also known as tanfanercept, a novel TNF-α inhibitor, is safe and effective for improving certain symptoms of dry eye disease, according to results of a phase 2 randomized, a double-blind...

Loading

Advertisement

For latest news and updates
Email-id is invalid

Meeting Coverage